Navigation Links
New International Pharmaceutical Company Pro Bono Bio Launched Today
Date:9/11/2011

pean and Russian manufacturers' approved facilities. In the mid-term the Company intends to augment these arrangements by building, with RUSNANO's backing, a state-of-the-art pharmaceutical plant close to Moscow and a sister plant in the UK to comply with European regulations, which together will supply global markets.

"RUSNANO Capital executes certain activities for RUSNANO. It is co-investor in international nanotechnology projects with significant economic or social potential. This project combines both elements. Pro Bono Bio's Sequessome technology is an example of nanotech that can considerably improve the treatment of a range of important diseases which have a significant impact on the Russian healthcare system." RUSNANO CEO Anatoly Chubais noted.

About Pro Bono Bio™

Pro Bono Bio is a new international healthcare company based on the experience in pharmaceutical product development, commercialisation and finance of Celtic Pharma Holdings in the UK, international capital, along with investment and support from RUSNANO in Russia. Pro Bono Bio has ambitious growth targets that will allow it to support a unique humanitarian mission.

Pro Bono Bio launched its first prescription medicine, FlexiseqTM, a new nanotechnology based pain treatment for osteoarthritis, in the UK in September 2011 with additional launches in Germany and Russia planned. The Company also plans to launch two further new products for the treatment of inflammatory skin disorders in the coming months. These new products are based on Pro Bono Bio's innovative Sequessome Technology™, which is able to physically absorb (sequester) and remove chemicals that are a key component in the pain and inflammation cascade.

Pro Bono Bio is also developing new products to treat haemophilia as well as novel antibiotics for the treatment of serious infections such as C. difficile, MRSA and Tuberculosis.


SOURCE Pro Bono Bio
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force
2. VWR International, LLC Acquires INTERNATIONAL P.B.I. S.p.A.
3. Bench International Expands Presence in Europe with Opening of Offices in Switzerland
4. Bacterin International to Present at Rodman & Renshaw Annual Global Investment Conference on September 12, 2011
5. Spaulding Clinical Announces Strategic Partnership with Clinigene International, India for Providing Comprehensive Early Clinical Solutions to Pharmaceutical and Biotech Clients
6. Chindex International, Inc. Announces Participation in Upcoming Investor Conferences
7. Pharmaceutics International, Inc. (Pii) Successfully Completes EMA and FDA Inspection
8. Urgent® PC Clinical Studies Results Scheduled for Presentation at International Continence Society
9. International St. Gallen Expert Panel Highlights Importance of Molecular Subtyping in Breast Cancer Treatment
10. PAREXEL International Reports Fourth Quarter and Fiscal Year 2011 Results
11. Chindex International, Inc. Reports Financial Results for the Second Quarter and First Half of 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 24, 2014  Actavis plc (NYSE: ... received a complete response letter from the U.S. ... Drug Application (NDA) for the fixed-dose combination (FDC) ... hypertension.   Photo - http://photos.prnewswire.com/prnh/20130124/NY47381LOGO ... the receipt of a complete response letter, Actavis ...
(Date:12/24/2014)... /PRNewswire/  -- Tianyin Pharmaceutical Inc. (NYSE Amex: ... in the patented biopharmaceutical, modernized traditional Chinese medicine ... released unaudited preliminary financial results for the first ... Year 2015 Ended September 30, 2014 Financial Highlights: ... $14.7 million in 1Q14 with gross margins improved ...
(Date:12/24/2014)... Dec. 24, 2014 Soligenix, Inc. (OTCQB: ... company developing products that address unmet medical needs ... announced today that on December 24, 2014 it ... The Company raised approximately $2.3 million in ... use the net proceeds from the offering to ...
Breaking Medicine Technology:Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 2Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 3Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 4TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 2TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 3TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 4TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 5TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 6TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 7TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 8TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 9TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 10TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 11TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 12Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3
... Jan. 10, 2011 Ascension Orthopedics, Inc., a market ... a European patent for a PyroCarbon humeral head design ... Modular Shoulder System released in September 2010. ... of Ascension Orthopedics, commented, "I am very pleased our ...
... Inc. (Nasdaq: RDEA ) today announced that ... Bayer HealthCare AG (Bayer) under the terms of their ... Ardea,s mitogen-activated ERK kinase (MEK) inhibitor compounds for cancer ... initiation of a Phase 2 clinical study evaluating BAY ...
Cached Medicine Technology:Ascension Orthopedics Granted Patent for PyroCarbon Humeral Head Design 2Ardea Biosciences Earns $15 Million Payment from Bayer HealthCare AG for Achievement of Important Clinical Milestone in Ongoing Collaboration 2Ardea Biosciences Earns $15 Million Payment from Bayer HealthCare AG for Achievement of Important Clinical Milestone in Ongoing Collaboration 3
(Date:12/25/2014)... Among early stage breast cancer patients who undergo chemotherapy ... will eventually develop leukemia as a result of their ... from a review of more than 20,000 breast cancer ... that the risk for developing treatment-related leukemia, though low, ... "The frequency of bone marrow cancers such as leukemia ...
(Date:12/25/2014)... ” was featured on NewsWatch as part of its monthly ... the iOS, Android, and Windows markets. Andrew Tropeano, a mobile ... and shared with viewers how this is an application for ... “A picture says a thousand words.” It’s true. There are ... because each picture holds a unique and special meaning. Photos ...
(Date:12/25/2014)... 25, 2014 Parker & Sons, Inc. ... service and affordable quality regarding heating, cooling and plumbing ... in 2014 by the “Queen of Clean” for impressive ... an impressive reputation over the years for providing outstanding ... range of contractor services for both homeowners and businesses. ...
(Date:12/24/2014)... December 24, 2014 Connie Casad, MD, ... functional medicine advocate with 30 years of practice experience ... evaluate the health benefits of dietary detoxification. The second ... participants following excellent results from test patients who just ... to explain her interest in conducting the study, Dr. ...
(Date:12/24/2014)... December 24, 2014 Dr. Vu Ho, ... expansion of his practice and med-spa with the addition ... growing list of cosmetic treatments and services. , “Silk ... the skin,” says Dr. Ho. “As a result it ... as wrinkles, sun spots, discolorations or blemishes.” , Similar ...
Breaking Medicine News(10 mins):Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2Health News:Parker & Sons Announces Recognition In 2014 By The “Queen Of Clean” For Impressive Contractor Services In Arizona 2Health News:Parker & Sons Announces Recognition In 2014 By The “Queen Of Clean” For Impressive Contractor Services In Arizona 3Health News:Connie Casad, MD, Now Accepting Test Participants for January Dietary Detoxification Study 2Health News:Connie Casad, MD, Now Accepting Test Participants for January Dietary Detoxification Study 3Health News:Dr. Vu Ho Expands Facial Plastic Surgery Practice to Include New Skin Care Treatment 2
... plastic surgeon, Dr. Michael Niccole says there are plenty of ways ... time to research and do the homework before jumping into a ... ... March 25, 2009 -- Adapting one,s priorities to today,s changed economy ...
... and LOS ANGELES, March 25 AmeriCares, a nonprofit ... than $1.4 million worth of lifesaving medicines and medical ... Darfur refugees in Chad. The medical aid will ... from serious injuries, infections, diarrhea and chronic diseases, in ...
... Ind., March 25 OBS Medical has entered ... of London-based insurer of medical malpractice for US ... a reduced cost to hospitals that implement OBS,s ... of clinical crises.Recognized by Frost and Sullivan as ...
... to weaknesses in the U.S. economy, plastic surgery ... to the newest national procedural statistics report from ... 2008, doctors performed over 12 million cosmetic plastic ... procedures. Surgical numbers dropped nine percent and minimally-invasive ...
... ULU) today announced that it has scheduled a ... 2008 financial results and provide a general business update on ... in the conference call please dial (800) 357-0498, for international ... minutes prior to the initiation of the teleconference. If ...
... official IRS determination letter. , ... New York, NY (Vocus) March 25, ... receipt of their official IRS determination letter. This letter confirms Angie,s Spa ... spa services for cancer patients undergoing chemotherapy. , , ,Thanks ...
Cached Medicine News:Health News:Orange County Plastic Surgeon Warns: When It Comes To The Face And Body, The Best Deal Could Cost More 2Health News:AmeriCares and International Medical Corps Partner to Bring Lifesaving Aid to Chad 2Health News:OBS Medical's Visensia Patient Monitoring Technology Lowers Cost of Medical Malpractice Insurance 2Health News:Recession cuts many, not all plastic surgery procedures 2Health News:ULURU Inc. Announces Conference Call to Discuss Financial Results for the Fourth Quarter and Year Ended December 31, 2008 and to Provide a Business Update 2Health News:Angie's Spa Receives Official Acknowledgment of Non-Profit Status 2
... Managing diabetes requires making decisions about insulin ... exercise. These decisions are guided by data ... information, and by the patterns that can ... Care Providers when the data is presented ...
... The Worlds First Solid-State Three-Color ... chosen to purchase over 3,000 Lumenis ... a busy practice, the Novus Varia ... lasers into a single, compact system ...
... Solid-State Three-Color Photocoagulator.,Retinal physicians throughout the ... 3,000 Lumenis multi-color photocoagulators.,For the retinal ... Novus Varia integrates green, yellow, and ... compact system that supports your treatment ...
The ring maintains the bag tension avoiding the development of posterior capsule pleats. It is also established to compensate the efforts induced during the bag retraction....
Medicine Products: